Open access

829 Tumor alpha-fetoprotein inhibits cholesterol and steroid metabolism in monocyte-derived dendritic cells
Paul Munson, Juraj Adamik, Lisa Butterfield

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A496-A497; DOI: 10.1136/jitc-2020-SITC2020.0829
831 E3 ubiquitin ligase Cbl-b deficient CD8+ T cells overcome Treg cell-mediated suppression through IFN-γ and induce robust anti-tumor immunity
SeongJun Han, Zhe Qi Liu, Douglas Chung, Michael St Paul, Carlos Garcia-Batres, Azin Sayad, Alisha Elford, Matthew Gold, Natasha Grimshaw, Pamela Ohashi

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A497-A498; DOI: 10.1136/jitc-2020-SITC2020.0831
840 Presence and distribution of immunosuppressive peptide P3028 in relation to immune phenotype of tonsillar cancer
Sabine Swoboda, Rebecca Rosberg, David Gomez Jimenez, David Askmyr, Malin Lindstedt, Lennart Greiff, Leif Håkansson

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A501-A502; DOI: 10.1136/jitc-2020-SITC2020.0840
850 Immunological considerations for developing optimal whole tumor cell-derived cancer vaccines
Flavio Salazar Onfray

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A506-A507; DOI: 10.1136/jitc-2020-SITC2020.0850
855 Cutaneous adverse events of immune checkpoint inhibitor therapy: incidence and types of reactive dermatoses
Thomas Le, Subuhi Kaul, Shannon Wongvibulsin, Laura Cappelli, Jarushka Naidoo, Yevgeniy Semenov, Shawn Kwatra

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A509-A510; DOI: 10.1136/jitc-2020-SITC2020.0855
857 LAMP1 targeting of the large T antigen of merkel cell polyomavirus elicits potent CD4+ T cell responses and prevents tumor growth
Claire Buchta Rosean, Claire Buchta Rosean, Pratima Sinha, David Koelle, Paul Nghiem, Teri Heiland

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A510-A511; DOI: 10.1136/jitc-2020-SITC2020.0857
861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells
Andrew Rankin, Edwina Naik

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A512-A513; DOI: 10.1136/jitc-2020-SITC2020.0861
868 PRELP-facilitated enhancement of MHC class I surface expression in B16F10 melanoma cells
Helene Schäfer, Karthikeyan Subbarayan, Barbara Seliger

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A515-A516; DOI: 10.1136/jitc-2020-SITC2020.0868
102 Cord-blood derived NK cells, and CAR-T cells, an attractive improved immunotherapy treatment to be considered for hematological malignancies
Mireia Bachiller García, Lorena Pérez-Amill, Anthony Battram, Alvaro Urbano-Ispizua, Beatriz Martín-Antonio

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A64; DOI: 10.1136/jitc-2020-SITC2020.0102
105 A third-generation human GUCY2C-targeted CAR-T cell for colorectal cancer immunotherapy
Trevor Baybutt, Adam Snook, Scott Waldman, Jonathan Stem, Ellen Caparosa, Alicja Zalewski

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A65-A66; DOI: 10.1136/jitc-2020-SITC2020.0105

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages